Concepedia

A major allergen gene-fusion protein for potential usage in allergen-specific immunotherapy

Fatimah Kussebi, Fariba Karamloo, Claudio Rhyner, Peter Schmid‐Grendelmeier, Maria Salagianni, Christian Mannhart, Mübeccel Akdiş, Z. Marković-Housley, Barbara R. von Beust, Thomas M. Kündig,

Journal of Allergy and Clinical Immunology · 2005 · 91 citations · 21 references

DOIFull text

Open access

Concepts

References

21

Immune Responses in Healthy and Allergic Individuals Are Characterized by a Fine Balance between Allergen-specific T Regulatory 1 and T Helper 2 Cells

Mübeccel Akdis, Johan Verhagen, Alison Taylor et al. · The Journal of Experimental Medicine · 2004 · 1.1K citations · Full text

, , +17

Role of interleukin 10 in specific immunotherapy.

Cezmi A. Akdiş, Thorsten Blesken, Mübeccel Akdiş et al. · Journal of Clinical Investigation · 1998 · 971 citations · Full text

, , +17

Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom☆☆☆★★★

Ulrich Müller, Cezmi A. Akdiş, Michael Fricker et al. · Journal of Allergy and Clinical Immunology · 1998 · 456 citations · Full text

, , +16

Blocking Antibodies Induced by Specific Allergy Vaccination Prevent the Activation of CD4+ T Cells by Inhibiting Serum-IgE-Facilitated Allergen Presentation

R. J. Joost van Neerven, T. Wikborg, G. Lund et al. · The Journal of Immunology · 1999 · 384 citations · Full text

, , +16

Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro.

Cezmi A. Akdiş, Mübeccel Akdiş, Thorsten Blesken et al. · Journal of Clinical Investigation · 1996 · 312 citations · Full text

, , +16